Development of a Prediction Model for Short-Term Remission of Patients with Crohn’s Disease Treated with Anti-TNF Drugs

Therapy with anti-tumor necrosis factor (TNF) has dramatically changed the natural history of Crohn’s disease (CD). However, these drugs are not without adverse events, and up to 40% of patients could lose efficacy in the long term. We aimed to identify reliable markers of response to anti-TNF drugs...

Descripción completa

Detalles Bibliográficos
Autores principales: Medina-Medina, Rosario, Iglesias-Flores, Eva, Benítez, Jose M., Marín-Pedrosa, Sandra, Salgueiro-Rodríguez, Isabel, Linares, Clara I., González-Rubio, Sandra, Soto-Escribano, Pilar, Gros, Beatriz, Rodríguez-Perálvarez, Manuel L., Cabriada, José L., Chaparro, María, Gisbert, Javier P., Chicano-Gálvez, Eduardo, Ortea, Ignacio, Ferrín, Gustavo, García-Sánchez, Valle, Aguilar-Melero, Patricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217828/
https://www.ncbi.nlm.nih.gov/pubmed/37240037
http://dx.doi.org/10.3390/ijms24108695

Ejemplares similares

Ejemplares similares